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ABSTRACT PAGE

In the yeast Saccharomyces cerevisiae, the essential SUMO protease Ulp1 is responsible
both for removing SUMO/Smt3 (small ubiquitin-like modifier) from specific target proteins
and for processing precursor SUMO into its conjugation-competent form. Ulp1 localizes
predominantly to nuclear pore complexes (NPCs) but has also been shown to deconjugate
sumoylated septins at the bud neck of dividing cells. How Ulp1 is directed to bud-neck
localized septins and other cytoplasmic deconjugation targets is not well understood.
Using a structure/function approach, we set out to elucidate features of Ulp1 that are
required for substrate targeting. To aid our studies, we took advantage of a catalytically
inactive mutant of Ulp1 that is greatly enriched at the bud-neck of dividing yeast cells. We
found that the localization of full-length Ulp1 to the bud-neck requires both SUMO and
specific structural features of Ulp1‘s catalytic domain. In our analysis, we identified a 218
amino acid-long, substrate-trapping mutant of the catalytic domain of Ulp1,
Ulp1(3)(C580S), that is necessary and sufficient for bud-neck localization. We used the
targeting and SUMO-binding properties of Ulp1(3)(C580S) to purify Smt3-modified proteins
from bacterial and yeast cell extracts. Furthermore, we find that the Ulp1(3)(C580S)
interacts robustly with monomeric forms human SU M 01, S U M 02 as well as SU M 02
chains, making it a potentially useful tool for the analysis of sumoylated proteins. In
summary, our study provides novel insights into how the Ulp1 SUMO protease is actively
targeted to its substrates in vivo and in vitro.
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INTR ODUCTIO N:
SUMO: A Post-translational modification
The human body consists of approximately 50 trillion cells. There are
around 200 different types of cells in the body including epithelial cells of the skin,
neurons in the brain, and contractile muscle cells to name a few. While these
cells have very different functions in the body, they are all composed of 4 basic
macromolecules including nucleic acids (DNA and RNA), lipids, carbohydrates
(sugars), and proteins. Proteins are the drivers of many processes in the cell
and have roles in metabolism, signaling, and cell structure. The human genome
project has uncovered that the human genome encodes approximately 25,000
genes. However, although every cell contains the same genetic material, not
every cell has the same characteristics and functions. Many differences between
cells can be traced to differences in protein expression. More importantly, posttranslational modifications of proteins, for example phosphorylation, acetylation,
ubiquitination, or sumoylation, are utilized to increase the diversity and function of
the proteome. Therefore, the total number of potential protein functions is far
greater than the actual number of proteins encoded inside a cell. Here, we
explore the functional consequences of SUMO-modification on sub-cellular
protein targeting during cell division (Fig. 1)
Sumoylation is the attachment of a 98 residue (-14 kDa) protein called
SUMO (small ubiquitin like modifier). SUMO is a conserved protein that shares
approximately 18% identity with ubiquitin and both proteins become covalently
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Figure 1. Post-translational modifications increase the functional diversity
of the cellular proteome.
(A) The human body is composed of 50 trillion cells with each cell containing
approximately 25,000 genes. (B) Cells are made of 4 basic macromolecules
including nucleic acids (DNA and RNA), lipids, sugars, and proteins. All cells
contain the same DNA but express different proteins. Picture from
http://www.olvmpusfluoview.com. (C) Proteins (red) can be modified by different
post-translational modifications that can alter the function of the protein and
increase the diversity of the cellular proteome. These modifications include
phosphorylation, methylation, acetylation, and sumoylation to name a few. (D)
Roles of post-translational protein modifications in a cell.
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attached to specific proteins in a reversible manner (Kerscher et al., 2006).
Ubiquitin is best known for its role in the targeted destruction of proteins including
key cell-cycle regulators but also holds many non-proteolytic functions (Chen and
Sun, 2009). Sumoylation, on the other hand, does not directly target proteins for
proteasomal degradation. Rather, modification of proteins with SUMO has been
shown to modulate various cellular processes, including cell-cycle regulation,
transcriptional activation, nucleocytoplasmic transport, DNA replication and
repair, chromosome dynamics, apoptosis, ribosome biogenesis, and formation of
nuclear bodies (Wang and Dasso, 2009). These functional distinctions between
ubiquitin and SUMO have been further blurred by the recent discovery of SUMOtargeted Ubiquitin Ligases (STUbLs) that enable SUMO to play an indirect role in
proteasome-mediated degradation (Perry et al., 2008).
SUMO proteins are highly conserved from yeast to humans.

Yeast cells

express one SUMO protein, Smt3, while vertebrates express three isoforms,
S U M 01, SUM02, and SUM 03 (Wilkinson and Henley, 2010). SUM02, SUM03
and yeast Smt3 can form SUMO chains. SUM01, on the other hand, lacks the
internal lysine required for polymerization and may function as a chain terminator
for SU M 02 and 3 chains (Matic et al., 2008). SUMO modified proteins contain
the sumoylation consensus motif T'-K-X-D/E where ^ is a hydrophobic residue
and X is any amino acid. All SUMO variants are conjugated to lysine residues of
specific proteins, but only a fraction of these target proteins are modified with
SUMO at any given time (Hannich et al., 2005; Wykoff and O'shea, 2005).
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In

metazoans,

the

dysregulation

of

sumoylation

adversely

affects

developmental processes and has been implicated in the progression of
neurodegeneration, cancer, and infectious diseases (Lamsoul et al., 2005; Sarge
and Park-Sarge, 2009; Subramaniam et al., 2009). Over a thousand sumoylated
proteins have been identified in yeast and humans, but only in a few cases has
the role of sumoylation been studied in detail (Makhnevych et al., 2009). In the
budding yeast, Saccharomyces cerevisiae, the ligation of SUMO to specific
substrate proteins requires both an E1 heterodimer (Aos1 and Uba2) to activate
SUMO, as well as E2 (Ubc9) and E3 (Siz1, Siz2, and Mms21) enzymes to
catalyze the amide bond formation between the COOH-terminal carboxyl group
of SUMO and the lysine side chain of acceptor proteins (Kerscher et al., 2006).

SUMO Interacting Motifs
Proteins can interact non-covalently with SUMO modified proteins through
the use of SUMO interacting motifs (SIMs). SIMs are characterized by a
hydrophobic core of amino acids (V/l-X-V/l-V/l) flanked by negatively charged
acidic amino acids (Hannich et al., 2005). Interaction with SUMO requires the
insertion of SIMs into the hydrophobic core of SUMO (Kerscher, 2007). The
variability in the composition of the hydrophobic core of SUMO as well as the
placement of charged amino acids allows SIMs to bind SUMO in either a parallel
or anti-parallel orientation with respect to the |32 strand of SUMO (Kerscher,
2007). Basic residues of SUMO are proposed to have a role in electrostatic
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interactions with negatively charged residues in SIM-containing proteins (Baba et
al., 2005; Hecker et al., 2006; Song et al., 2005).

SUMO Proteases
Yeast contain two SUMO proteases while humans utilize six SUMO
proteases termed sentrin proteases (SENPs) (Mukhopadhyay and Dasso, 2007).
Yeast proteases are termed ubiquitin-like protease 1 and ubiquitin-like protease 2
(Ulpl and Ulp2). Ulpl is a 72 kDa protein encoded on the YPL020c open
reading frame (ORF) on chromosome 16 (Li and Hochstrasser, 1999).

Both

Ulpl and Ulp2 utilize a conserved cysteine protease domain that can remove the
SUMO moiety from modified proteins. Ulpl has two contrasting cellular
functions. Ulpl facilitates sumoylation in the context of processing the SUMO
precursor by removing the amino acid residues ATY.

The removal of ATY

exposes a C-terminal di-glycine motif thus making SUMO competent for
conjugation. Conversely, Ulpl also facilitates desumoylation by removal of
SUMO from nuclear and cytosolic proteins after conjugation (Li and
Hochstrasser, 1999). SUMO deconjugation involves the cleavage of an amide
bond between the C-terminus of SUMO and the epsilon amine group of the target
lysine (Kerscher et al., 2006). Therefore, impairment of Ulpl results in the
accumulation of SUMO conjugates and the inability to carry out de novo
sumoylation. The resulting lack of mature SUMO has been shown to adversely
affect cellular DNA repair processes, the processing and nuclear export of the
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60S pre-ribosomal particle, nuclear-cytoplasmic trafficking, and cell viability
(Lewis et al., 2007; Palancade et al., 2007; Stade et al., 2002; Zhao and Blobel,
2005). Ulp2, on the other hand, does not contain SUMO processing activity and
is not an essential gene, but it is required for normal chromosome stability and
recovery from cell cycle arrest (Kroetz et al., 2009). Recent evidence suggests
that Ulp2 and its mammalian orthologs Susp1/SENP6 and SENP7 play a role in
the removal of SUMO and SUMO chains from nuclear proteins (Baldwin et al.,
2009; Bylebyl et al., 2003; Kroetz et al., 2009; Mukhopadhyay et al., 2006;
Uzunova et al., 2007).
The substrate specificity of SUMO proteases is at least in part regulated
through their localization (Mukhopadhyay and Dasso, 2007).

For example,

certain yeast (Ulp2) and vertebrate (SENP6 and SENP7) SUMO proteases
localize within the nucleus. In contrast, both yeast (U lp l) and vertebrate (SENP1
and SENP2) SUMO proteases reside at the nuclear envelope (NE) through their
interactions with the NPC (Li and Hochstrasser, 2003; Panse et al., 2003;
Strunnikov et al., 2001; Zhang et al., 2002).

Distinct domains have been

identified that are required for Ulpl NPC localization (amino acid residues 1-403)
and SUMO processing (amino acid residues 404-620) (Li and Hochstrasser,
2003; Makhnevych et al., 2007; Panse et al., 2003; Zhao et al., 2004). The Ulpl
localization domain promotes interaction with karyopherins, soluble proteins that
mediate transport across the nuclear envelope, and help localize Ulpl to the
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MSVEVDKHRNTLQYHKKNPYSPLFSPISTYRCYPRVLNNPSESRRSASFSG
IYKKRTNTSRFNYLNDRRVLSMEESMKDGSDRASKAGFIGGIRETLWNSGK

Region 1
(l-150aa)
Kap 121

YLWHTFVKNEPRNFDGSEVEASGNSDVESRSSGSRSSDVPYGLRENYS

SDTRKHKFDTSTWALPNKRRRIESEGVGTPSTSPISSLASQKSNCDSDNSI
TFSRDPFGWNKWKTSAIGSNSENNTSDQKNSYDRRQYGTAFIRKKKVAKQN
INNTKLVSRAQSEEVTYLRQIFNGEYKVPKILKEERERQLKLMDMDKEKDT
GLKKSIIDLTEKIKTILIENNKNRLQTRNENDDDL VF
VKEKKISSLERKHKDYLNQKLKFDRSILEFEKDFKRYNEILNERKKIQEDL
KKKKE QLAKKKL

Region 2
(151-340aa)
Kap95-Kap60

Coiled Coil
(341-403aa)
NES

VPELNEKDDDQVQKALASRENTQLMNRDNIEITVRDFKTLAPRRWLN TII

Region 3

EFFMKYIEKSTPNTVAFNSFFYTNLSERGYQGVRRWMKRKKTQIDKLDKIF
/ 404 —621^
TPINLNQSHWALGIIDLKKKTIGYVDSLSNGPNAMSFAILTDLQKYVMEES
catalytic domain
KHTIGEDFDLIHLDCPQQPNGYDCGIYVCMNTLYGSADAPLDFDYKDAIRM
RRFIAHLIL3DALK*

■ “Putative SIM
■ =NLS

=Aspartic Acid 451
C=Cysteine 580

Figure 2. Ulpl amino acid sequence and functional elements.
Ulpl is a 621 amino acid protein that can be divided into 4 functional elements.
Region 1 comprises residues 1-150 and is the binding site for the importin
karyopherin 121 (Kap121). Region 2 composes residues 150-340 and is the
binding site for karyopherin 95 and karyopherin 60 (Kap95-Kap60). Region 2
also contains a nuclear localization sequence (NLS) that is highlighted in green.
U lpl contains a coiled coil domain in residues 341-403 that also may contain a
putative nuclear export signal (NES). Region 3 composes residues 404-621 and
is the catalytic domain of the protease. A SUMO-binding surface (SBS) critical
for U lp l’s interaction with SUMO is highlighted in bold. Aspartic acid residue 451
(D) that forms a critical salt-bridge interaction with Smt3 is highlighted in yellow.
The catalytic cysteine (C), residue 580, is highlighted in red. Putative SIMs are
highlighted in blue italics.
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nucleoplasmic side of the NPC.
The Ulpl localization domain can be subdivided into region 1 (Kap121
binding domain) and region 2, (Kap60 and Kap95 binding domain) (Fig. 2).
Juxtaposed to the NPC localization domain of Ulpl is a coiled-coil (cc) domain
with a putative nuclear export signal, and region 3, the catalytically active,
conserved ubiquitin-like protease domain (UD) of Ulpl (Li and Hochstrasser,
2003; Makhnevych et al., 2007; Panse et al., 2003). Only regions 1 and 2 are
involved in Ulpl localization to the NPC, and karyopherins seem to play a
redundant role in NPC-anchoring.

NPC-association of Ulpl requires several

proteins, including the nucleoporins Nup60 and Nup84, the silencing protein
Esc1, and the myosin-like proteins Mlp1/2 (Lewis et al., 2007; Palancade et al.,
2007; Zhao et al., 2004). Together these proteins may provide a scaffold for the
functional regulation and substrate access of Ulpl at the NPC.
The identification of NPC-localization domains in Ulpl has done little to aid
our understanding of how SUMO proteases are targeted to their respective
substrates (Li and Hochstrasser, 2003; Zhang et al., 2002).

One possibility is

that SUMO proteases may contain structural features which allow for noncovalent interactions with SUMO and SUMO-modified proteins as they enter the
nucleus.

Indeed,

conserved

SUMO-interacting

motifs,

SIMs,

have

been

predicted in the yeast SUMO protease Ulp2, as well as mammalian SENP1,2,6,
and 7 (Kroetz et al., 2009; Matunis et al., 2006; Mukhopadhyay and Dasso,
2010). Even though SIMs have not been identified in U lpl, the crystal structure

of the catalytic domain (region 3) bound to Smt3 reveals that both proteins
interact through multiple residues that are distributed across a SUMO-binding
surface (SBS) on the SUMO protease. Only the carboxy-terminus of bound Smt3
is inserted into a hydrophobic tunnel that leads towards U lp l’s active site. SUMO
processing and deconjugation require an active-site cysteine residue that resides
at the end of this tunnel. It has been suggested that this configuration may allow
for the accommodation of many different sumoylated proteins, as well as SUMO
precursors (Mossessova and Lima, 2000).
Ulpl and several other SUMO proteases play important roles in mitosis
(Dasso, 2008; Li and Hochstrasser, 1999).

In budding yeast, loss of Ulp1-

mediated desumoylation leads to cell cycle progression defects and cell death (Li
and Hochstrasser, 1999). This observation suggests that Ulpl plays a key role in
the sumoylation dynamics of important cell cycle regulatory proteins.

Though

these cell cycle-specific targets have eluded identification, several nuclear and
cytosolic proteins involved in DNA replication and mitosis have been identified as
Ulpl desumoylation substrates (Leisner et al., 2008; Stelter and Ulrich, 2003;
Takahashi et al., 2000). How the NPC-localized Ulpl is targeted to these mitotic
substrates, especially those that are localized in the cytosol, is not entirely clear.
In budding yeast the nuclear envelope does not break down during mitosis and
access to cytosolic desumoylation targets is therefore not automatic. It has been
reported that during mitosis, Kap121 blocks access of Ulpl to its NPC-binding
site, and thus promotes an interaction of U lpl with septins (Makhnevych et al.,
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2007). A deletion mutant of Ulpl lacking region 2 (A2), lacking the Kap60 and
Kap95 binding domain, has previously been shown to localize to septins in a
Kap121 -dependent manner (Makhnevych et al., 2007). Curiously, it has recently
been shown that region 2 also plays a role in nucleolar accumulation of Ulpl after
ethanol-induced stress (Sydorskyy et al., 2010).

Septins
One set of cytosolic substrates of the Ulpl SUMO protease are the septins
(Makhnevych et al., 2007; Takahashi et al., 2000). The septins in budding yeast
comprise an evolutionarily conserved class of GTPases that are implicated in
bud-site selection, bud emergence/growth, microtubule capture, and spindle
positioning (Spiliotis, 2010). Members of the septin family in yeast include Cdc3,
Cdc10, Cdc11, Cdc12, and Shs1/Sep7. These proteins are unique because they
can form filaments that assemble into a ring structure and mark the site of new
bud formation during cell division. At the end of mitosis, this ring separates and
resembles a double collar residing at the junction between the mother and
daughter cells.
The

septins

Cdc3,

Cdc11,

and

Shs1

are

subject

to

sumoylation.

Sumoylation of the septins occurs very briefly from the onset of anaphase to
cytokinesis, with SUMO being attached only to the mother-side of the double
septin ring collar (Johnson and Blobel,

1999; Makhnevych et al., 2007;

Takahashi et al., 1999). Cell cycle (G2/M) arrest with nocodazole, a microtubule
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depolymerizing drug, greatly increases SUMO conjugation to septins (Takahashi
et al., 2000). Septin sumoylation in budding yeast is mediated by the SUMO E3
ligase Siz1 (Johnson and Gupta, 2001; Takahashi et al., 2001). During most of
the cell cycle, Siz1 resides in the nucleus. However, at M-phase, Siz1 exits the
nucleus to sumoylate septin proteins and possibly other cytosolic substrates
(Takahashi et al., 2008).

Deletion of SIZ1 from cells abolishes septin

sumoylation while causing only mild growth and cell-cycle progression defects.
At the end of mitosis, the septins are desumoylated by Ulpl even though Ulpl
remains visibly enriched at the NPC (Johnson and Blobel, 1999; Makhnevych et
al., 2007; Takahashi et al., 2000). During mitosis, the septins are the most highly
sumoylated proteins in the cell (Johnson and Blobel, 1999). However, the role of
septin sumoylation is not well understood.

A mutant yeast strain lacking

sumoylation sites in the septins Cdc3, Cdc11, and Shs1 showed a drastically
decreased overall level of sumoylation in the cell (Johnson and Blobel, 1999).
Furthermore, the triple mutant showed improper septin ring disassembly and
retained unassembled septin rings from previous divisions.

However, the triple

mutant showed no growth defects and no sensitivity to stress conditions (Dasso,
2008; Johnson and Blobel, 1999). Notably, two other septins, Cdc10 and Cdc12,
are expressed during vegetative growth and have been shown by proteomic
analysis to be sumoylation targets (Dasso, 2008).

In the triple mutant, it is

possible that Cdc10 and Cdc12 compensate for the lack of septin sumoylation on
Cdc3, C d d 1 and Shs1. This idea is supported by the finding that triple mutant is
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synthetically lethal at 25°C in a Cdc12 temperature sensitive strain (Dasso,
2008).

Specific Aims of Thesis
Which mitotic sumoylation targets must be desumoylated to ensure proper
cell-cycle progression, and how does Ulpl target these proteins?

To answer

these questions, we sought to identify features of Ulpl required for substratetargeting in vivo and in vitro. Here we identify and analyze distinct mutations in
Ulpl that affect its targeting and retention to sumoylated target proteins at the
bud-neck of dividing cells. We find that Smt3-interactions comprise an important
aspect of the sub-cellular targeting of Ulpl to its substrates.

Our findings are

confirmed by biochemical analyses that focus on the SUMO-binding properties of
Ulpl (3)(C580S)

a truncation

mutant that

interacts

avidly with

SUMO

and

sumoylated proteins in vivo and in vitro. Significantly, this study adds important
new details to our understanding how Ulpl

interacts dynamically with its

substrates and also provides potentially useful new directions to the study of
Ulpl-interacting proteins.
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M ATERIALS AND METHODS:

Yeast strains, media and plasmids.
Yeast strains and plasmids used in this study are listed in Table 1. Yeast
media preparation and manipulation of yeast cells was performed as previously
published (Guthrie and Fink, 1991).

Yeast strains were grown at 30°C unless

otherwise indicated.

Table 1.

MHY500

BY4743
YOK
1611
YOK
1474
YOK
1490
YOK
1861

Mata his3-A200 leu23,112 ura3-52 iys2801trp1-1
gal2
MATa leu2A0 met 15AO
ura3A0
MHY500

u

u

YOK
1479
YOK
2016
YOK

“

(Li and Hochstrasser,
2003)

(Winzeler et al., 1999)
ULP1-GFP/LEU2
(BOK454)
Uj^p-j(C580S) _
GFP/LEU2
(BOK544)
ULP1(Reg1)~
GFP/LEU2
(B O K543)
UILP1 (Reg2)~
GFP/LEU2
(BOK 677)
ULP1(A2)-GFP/LEU2
(BOK 536)
ULP1(D451NC580^ GFP/LEU2
(BOK 667)
ULP1(Reg3)~
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This study
This study

This study

This study

This study
This study

This study

1839
YOK
1907
YOK
1903
YOK
2203

<<

YOK
1828
YOK
2157

u

YOK
1857

u

YOK
2204

GFP/LEU2
(BOK 633)
ULP1 (Reg3(C580S))GFP/LEU2
(BOK 662)
ULP1((Reg3ASBS(C58
0S))-GFP/LEU2
(BOK 687)
ULP1(SBS)~
GFP/LEU2
(BOK 696)
ULP1((Reg3(ts))~
GFP/LEU2
(BOK 635)
ULP1((Reg3(tsC580S))~
GFP/LEU2
(BOK 776)
SMT3-GFP/LEU2
(BOK 642)
Cdc3-CFP/L E U2 +

YOK
2205

YOK 44
YOK
1995

smt3-331

YOK 847

ubc9-1

YOK
1910

This study

This study

This study

This study

(Panse et al., 2003)

fJ I_ p -j(C 5 8 0 S )_

(Nishihama et al.,
2009)

GFP/URA3
(BOK 789 + BOK 738)
Cdc3-CFP/LE U2 +
Ulp 1(Reg3(C580S))GFP/URA3
(BOK 789 + BOK 740)

(Nishihama et al.,
2009)

U I_ p -j(C 5 8 0 S )_

(Biggins et al., 2001)
This study

GFP/LEU2
(BOK 544)

ULP1(C580S)GFP/URA3
(BOK 738)
SMT3-GFP/URA3
(BOK 658)

YOK
2065
YOK
2144
GBY1

This study

u

(Betting and Seufert,
1996)
This study

This study
(Bylebyl et al., 2003)

MATa smt3
R 11,15,19..TRP1
GBY1

[ J j_ p -f(C 5 8 0 S ) _

GFP/LEU2
(BOK 544)
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This study

yDS880

MA 7a-inc ade2-101 his3200 Ieu2-1:: GAL-HOLEU2 Iys2-801
RAD53::FLAG-HIS3
sizV/.NAT
siz2:: HPH sml 1:: KAN
trp1-63 ura3-52 VIIL::TRP-HO site-LYS2

YOK
2067
YOK
2143
kap121ts

YOK
1487
YOK
1488
YOK
1944
AH 109

YOK
2173

YOK
2175

kap121::ura3::HIS3 ura352 his3A200 trp1-1 Ieu23,112 Iys2-801
kap121ts

(Schwartz et al., 2007)

UI_P1(C580S)GFP/URA3
(BOK 738)
SMT3-GFP/URA3
(BOK 658)
pR S 314-kap 121 -34

ULP1-GFP/LEU2
(BOK 454)
p j (C580S) _

kap121ts

GFP/LEU2
(BOK 544)
ULP1(Reg3(C580S))GFP/LEU2
(BOK 662)

kap121ts

MATa, trp 1-901, leu2-3,
112, ura3-52, his3200,gal4A, gal80A,
L YS2::GAL 1UASGAL1TATAHIS3, GAL2UASGAL2TATA-ADE2,
URA3::MEL 1UASMEL1T
ATA-lacZ, MEL1
AH109

AH 109

This study

This study
(Leslie et al., 2002)

This study
This study

This study

Clontech, CA
Cat. # 630444

ULP1 (Reg3(C580S))pOAD/LEU2 + SMT3pOBD/TRPI
(BOK 641 + BOK 295)
ULP1 (Reg3(D451N})pOAD/LEU2 + SMT3pOBD/TRP1
(BOK 796 + BOK 295)
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This study

This study

YOK
2177

AH 109

YOK
2181

AH109

YOK
2212

AH 109

YOK
2183

AH 109

YOK
2185

AH 109

YOK 428

YOK
1398

ulp1::KAN (segregant of
heterozygous diploid
ULP1 /ulp 1::KAN in
BY4743 ( OpenBiosystems,
Huntsville, A L - Cat.#
YSC1021-671376)
Wildtype (YOK
821 xnup 170A::G418
CDC3-YFP/HIS5)

ULP1 (Reg3(ts))~
pOAD/LEU2 + SMT3pOBD/TRP1
(BOK 645 + BOK 295)
ULP1 (Reg3(tsC580S))pOAD/LEU2 + SMT3pOBDfTRPI
(BOK 775 + BOK 295)
ULP1 (Reg3(D451N
C580S))-pOAD/LEU2 +
SMT3-pOBD/TRP1
(BOK 799 + BOK 295
SMT3-pOAD/LEU2 +
SLX5 pOBD/TRP1
(BOK 295 + BOK 289)
vector-pOAD/LEU2 +
vector pOBD/TRP1
(BOK 312 + BOK 313)
ulp 1ts/TRP/NA T
GPD-FLAGSMT3gg/pRS425

This study

This study

This study

This study

This study

This study

This study

DNA fragments containing Ulpl under the control of its endogenous promotor
were amplified from yeast genomic DNA and placed in-frame with a carboxyterminal GFP tag in the CEN/LEU2 plasmid pAA3 (Sesaki and Jensen, 1999).
Primer pairs used for full-length Ulpl amplification were OOK2 (ULP1 (-310 to 294)) and OOK3 (ULP1 (+1842 to +1863)). To prepare truncated and mutated
Ulp1-GFP constructs listed in Table 1, Quikchange XL Site-Directed Mutagenesis

16

(Stratagene) and Phusion Site-Directed Mutagenesis kits (Finnzyme) were used
according to manufacturer’s instruction.

Primer sequence information for the

construction of individual mutants and truncations are available upon request. All
constructs were sequenced verified.

Additionally, activity of tagged Ulpl

constructs was confirmed in complementation assays. For two-hybrid constructs,
ORFs of the indicated genes were PCR-amplified and homologously recombined
into gapped pOAD and pOBD2 vectors (Yeast Resource Center, WA).

To

overexpress and purify Ulpl truncations from bacteria, the respective Ulpl
fragments were PCR-amplified and cloned into pMALc-HT (a gift from Sean
Prigge, JHSOM), thereby adding an in-frame maltose-binding protein (MBP)
module followed by a TEV protease cleavage site and a His6 epitope tag. Ulpl
derivatives were expressed as MBP fusions in BL21 Star (DE3) cells containing a
pRIL plasmid expressing several rare-codon tRNAs (a gift from Sean Prigge,
JHSOM, MD).

Cdc3-CFP/LEU2 plasmid YCp-111 (BOK 789) was a kind gift

from Ryuichi Nishihama in John Pringle’s lab.

Yeast Two-Hvbrid Assays
Gal4-Activation-domain (AD) fusions of ULP1 and the indicated ULP1
mutants in pOAD were transformed into the AH 109 reporter strain expressing a
Gal4-DNA-binding-domain

(BD)

fusion

of

SMT3

in

pOBD.

Two-hybrid

interactions were scored by streaking on dropout media lacking adenine.
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Pulldown assays, affinity purification, and protein extracts:
Frozen bacterial cell pellets from 200ml of IPTG-induced BL21 Star (DE3)
cells were thawed on ice and resuspended in 2ml 1x phosphate buffered saline
(PBS) containing 1x Halt Protease Inhibitor Cocktail (Pierce Cat. # 78430). Icecold cells were sonicated using a Branson Sonifier and extracts were cleared by
centrifugation at 15kRPM (21,000 RCF) for 8 minutes at 4°C. Cleared bacterial
extracts were added to 15 mL conical tubes and diluted using 4ml 1x PBS
containing the protease inhibitor cocktail.

MBP-tagged proteins (MBP-Ulp1(3),

U lpl (3)(C580S) or Ulpl (3)(C580S)ASBS) were bound to 5ml columns containing
300/ul amylose resin (New England Biolabs) and washed extensively with 1x
PBS.
passed

Whole yeast cell extracts containing the indicated target proteins were
over

the

amylose

resin

and

proteins

bound

to

MBP-Ulp1(3),

Ulpl (3)(C580S) or Ulpl (3)(C580S)ASBS were eluted with 100mM maltose or SDSPAGE sample buffer.

For SUMO pulldown experiments, recombinant MBP-

Ulp1 (3)(C580S) or MBP-Ulp1 (3) was incubated with SUMO-1 or SUMO-2 agarose
(Boston Biochem) in 1 ml of 1xPBS with protease inhibitors (Thermo Scientific).
Proteins bound to the agarose beads were washed in 1xPBS and eluted with 1x
SDS-PAGE sample buffer. All protein extracts were run out on NOVEX 4-12%
BIS-TRIS gradient gels (invitrogen #NP0321) using MOPS-SDS running buffer
(Invitrogen #NP0001).
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Fluorescent Microscopy
Unless otherwise noted, cells were grown in rich media, G2/M arrested
using nocodazole (15 /vg/ml/3h/30°C), washed in 2% dextrose, and harvested by
centrifugation.
with

a

Retiga

Images of live cells were collected using a Zeiss Axioskop fitted
SRV

camera

(Q-imaging),

i-Vision

software

(BioVision

Technologies), and a Uniblitz shutter assembly (Rochester, NY). Pertinent filter
sets for the above applications include CZ909 (GFP), XF114-2 (CFP), XF104-2
(YFP) (Chroma Technology Group).

Images were normalized using i-Vision

software and pseudo-colored and adjusted using Adobe Photoshop software
(Adobe Systems Inc.).

In vitro ubiquitvlation reactions, recombinant proteins, and antibodies:
In vitro ubiquitylation assay - enzymes and substrates used in our in vitro
ubiquitylation assays were quantified using a Protein 230 kit on the Agilent 2100
Bioanalyzer according to the manufacturer’s instructions. 10x ubiquitylation
buffer, E1 enzyme (Uba1), ATP, and 20x ubiquitin were provided in a commercial
ubiquitylation kit (Enzo # BML-UW0400). Ubiquitylation buffer, IPP (100 U/ml),
DTT (50 pM), E1 (Uba1), E2 (Ubc4), and E3 enzymes (RNF4) were combined
with purified SU M 02 chains (#ULC-210 -- Boston Biochem, MA) and ubiquitin.
Reactions totaled 27 pL and were incubated at 30°C for three hours. Reactions
were stopped by adding an equal volume of SUTEB sample buffer (0.01%
bromophenol blue, 10 mM EDTA, 1% SDS, 50 mM Tris at pH 6.8, 8 M Urea)
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containing DTT (5 pL of 1 M DTT/1 mL SUTEB sample buffer). Protein products
were boiled in a 65°C heat block for ten minutes and analyzed by western blot
with anti human SUMO-2 antibody. Anti-human SU M 02 # BML-PW0510-0025
(ENZO Life sciences, PA), anti-GFP:

JL8 # 632380 (Clontech, CA), anti-

FLAG(M2) #F3165 (Sigma-Aldrich, MO), anti-PGK: 22C5 # 459250 (Invitrogen,
CA).

Measurement of Ulp1 3(C580S)-SUMO-1 binding affinity using surface plasmon
resonance:
Affinity constants of Ulp1 3(C580S) and SUMO-1 were determined by Affina
Biotechnologies (Stamford CT) using a Biacore 3000 instrument.

Biotinylated

SUMO-1 (Boston Biochem., Cat# UL-725) was immobilized on research grade
streptavidin-coated sensor chips (Sensor Chip SA, Biacore Inc.) that were
pretreated according to the manufacturers instructions.

MBP-Ulp1 3(C580S) was

injected at a flow rate of 20 jil/min in 20 mM sodium phosphate, 150 mM NaCI,
0.05% P-20, 1 mg/ml BSA, pH 7.4 (running buffer) for 3 min. Equilibrium binding
data of MBP-Ulp1 3(C580S)-SUMO-1 were calculated using the BIAevaluation
software (Biacore Inc.).
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RESULTS:
Ulp1 localization to the nuclear envelope and the septin ring.
As part of a larger study to identify how Ulp1 is targeted to its mitotic
desumoylation substrates, we analyzed the localization of green fluorescent
protein (GFP)-tagged versions of both the full-length wildtype Ulp1 (WT) and a
catalytically inactive mutant of Ulp1 (Ulp1(C580S)) in G2/M-arrested yeast cells.
The C580S mutation replaces the catalytic cysteine with a serine residue,
rendering the Ulp1 SUMO protease catalytically inactive (Li and Hochstrasser,
1999).

Both fusion proteins were expressed under the control of the Ulp1

promotor on low-copy plasmids, and images were collected using a fluorescent
microscope. Consistent with its localization to nuclear pore complexes, wildtype
Ulp1 only stained the nuclear envelope of arrested yeast cells (Fig. 3 A - left).
Unexpectedly, however, full-length Ulp1(C580S) was enriched both at the bud-neck
and the nuclear envelope of G2/M arrested cells (Fig. 3 A - right). This bud-neck
localization of full-length Ulp1 is reminiscent of the localization of the septin ring.
Several sumoylated septins have been shown to be Ulp1 substrates and we
show that the septin Cdc3 is higly sumoylated during G2/M arrest (Fig 3B).
Indeed we found that the localization of Ulp1(C580S) at the bud-neck corresponds
to the position of the septin ring (Fig 3C - bottom). Specifically, cyan fluorescent
protein (CFP)-tagged septin, Cdc3-CFP, colocalized with Ulp1(C580S) when septins
were sumoylated during G2/M arrest (noc) (Fig. 3C).
resides at the bud-neck localized septin ring.
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Therefore, Ulp1(C580S)

A.

B.

Ulpl(WT)-GFP Uipt<CM0S)-GFP

noc

log

Cdc3-YFPSUM0>
- Cdc3-YFP

c.
U |P1(C580S)

(J|pl(3)(Csaos>

GFP

Cdc3-CFP

Merged
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Figure 3. Localization of Ulp1 and the catalytically inactive Ulp1(C580S) in
dividing yeast cells. (A) Upper panel: Yeast cells (MHY500) were transformed
either with a low-copy plasmid expressing GFP fusions of Ulp1 or the catalytically
inactive Ulp1(C580S) mutant. Shown are representative images indicating the
localization of GFP-tagged Ulp1 and Ulp1(C580S) after nocodazole-induced G2/M
arrest (YOK 1611 and YOK 1474). Note that only the Ulp1 (C580S> mutant can be
visualized at the bud-neck of arrested cells. The arrowhead denotes the position
of the bud-neck. (B) Confirmation of sumoylation of Cdc3. Whole cell extracts
(WCEs) from yeast cells expressing the YFP-tagged septin Cdc3 (YOK 1398)
were treated with nocodazole (noc) or grown logarithmically (log) prior to
preparation of whole cell extracts. Extracted proteins were then separated on
SDS-PAGE gels and probed with the JL-8 antibody (see materials and methods)
to detect Cdc3-YFP and slower migrating sumoylated Cdc3-YFP adducts.
Identity of sumoylated Cdc3-YFP bands was confirmed by comparing gel-shift
assays with untagged and FLAG-tagged Smt3 (data not shown). (C)
Colocalization of Cdc3 and Ulp1. A strain coexpressing full-length uip1(C580S)GFP (green) and Cdc3-CFP (red) (strain YOK 2204) was arrested in G2/M and
then observed using a fluorescence microscope with the appropriate filter sets
(left panel). Indicated (arrow heads) are septin-localized pseudo-colored Ulp1GFP (green) and Cdc3-CFP (red) and the merged image (overlay). Also shown,
for comparison (right panel), is the colocalization of the Ulp1(3)(C580S)-GFP
truncation and Cdc3-CFP (strain YOK 2205). Ulp1(3)(C580S)-GFP is further
described in Fig. 5.

Our data suggest that introducing the C580S mutation into the catalytic
domain of Ulp1 somehow alters the subcellular distribution of this SUMO
protease mutant to associate with a bud-neck associated substrate, possibly a
sumoylated septin protein.

Localization changes have also been reported for

catalytically inactive, substrate-trapping mutants of phosphatases that form
stable complexes with their substrates in vivo (Flint et al., 1997).

SUMO is required for Ulp1 localization to the septin-ring.
Next, we tested whether the C580S mutation that visually increased the
ability of full-length Ulp1 to associate with the septin ring in vivo was, in fact,
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SUMO-dependent. For this purpose, the Ulp1 <C580S) construct was expressed in
two Smt3 mutants (smt3-331 and sm t3-R11,15,19) or two SUMO pathway
mutants (ubc9-1, s iz IA siz2A) (Betting and Seufert, 1996; Biggins et al., 2001;
Bylebyl et al., 2003; Schwartz et al., 2007; Takahashi et al., 1999; Takahashi et
al., 2001). Logarithmically growing cells of each mutant were arrested in G2/M,
and images were collected to assess the septin ring localization of Ulp1(C580S) in
comparison to a SMT3 wildtype strain. In our analyses, we found that in both the
absence of SUMO chains (in the R11,15,19 mutant) and improperly formed
SUMO chains (in the smt3-331 mutant), the localization of Ulp1(C580S) to the
septin ring was reduced but not abolished (Fig. 4A).

However, we obtained

different results in the ubc9-1 strain, a mutant of the SUMO E2 conjugating
enzyme which impairs SUMO conjugation, and the s iz IA siz2A strain, a SUMO
E3 ligase double mutant that lacks sumoylation of septins and many other
proteins (Betting and Seufert, 1996; Johnson and Gupta, 2001; Takahashi et al.,
2001). Consistent with a role for Smt3 in the localization of Ulp1(C580S), we were
unable to detect septin ring localization of Ulp1(G580S) in ubc9-1 and siz IA siz2A
strains. However, Ulp1(C580S) was retained at the nuclear envelope (Fig. 4A). As
an additional control, the septin ring localization of GFP-tagged Smt3 was
undetectable in both ubc9-1 and siz1Asiz2A strains (Fig. 4B).
In summary, Smt3 is required for Ulp1 localization to the bud-neck that
comprises the septin ring.

Therefore, Ulp1 is targeted to the septin ring of

dividing cells in a SUMO-dependent fashion. Our data also suggest that the
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A.

B.
_________ Ulp1(C580S).GFP

Smt3-GFP

siz I A ! s iz IA

ubc9-I

Figure 4. SUMO is required for the localization of Ulp1(C580S) to the septin
ring. (A) The indicated mutants (smt3-331, ubc9-1, smt3-R11,15,19, siz1Asiz2A)
and a wildtype control strain (WT) were transformed with a plasmid expressing
GFP-tagged Ulp1(C580S).
Shown are representative images indicating the
localization of GFP-tagged Ulp1(C580S) after G2/M arrest.
The septin ring
localization of Ulp1(C580S) is indicated when present (arrowheads). Note that
Ulp1(C580S) fails to localize to the septins in SUMO-conjugating and -ligating
enzyme mutants (ubc9-1 and siz IA siz2A, respectively). (B) Septin localization of
Smt3-GFP is absent in ubc9-1 and s iz IA siz2A strains. Localization of SUMOGFP was visualized in G2/M-arrested wildtype (WT), ubc9-1, and s iz IA siz2A
strains using fluorescence microscopy. Position of the septin ring is indicated
(arrow heads).
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formation of SUMO chains on substrates may enhance this targeting of Ulp1

Distinct and separate Ulp1 domains are required for localization to the
septin ring.
Our finding that a single point mutation in Ulp1, C580S, dramatically
enhanced the localization of full-length Ulp1 to the septin ring in a SUMOdependent fashion warranted a more detailed analysis of the targeting domains
in Ulp1.

Therefore, we generated a collection of GFP-tagged Ulp1 truncations

and domains that were expressed under control of the Ulp1 promotor.

We

reasoned that the truncations and domains of Ulp1 that retained substratetargeting information would also localize to the septin ring in G2/M-arrested cells.
In all, we assessed the localization of ten GFP-tagged constructs in comparison
to full-length wildtype Ulp1 (WT) and full-length Ulp1(C580S) (C580S). Our choice
of individual constructs was guided by previous findings that Ulp1 consists of
functionally separate domains. These domains include a Kap121-binding domain
with a role in septin localization (region 1), a Kap95-Kap60-binding domain with a
role in NPC anchoring (region 2), a coiled-coil domain harboring a nuclear export
signal (CC), and the catalytic UD domain (region 3) (Li and Flochstrasser, 2003;
Makhnevych et al., 2007; Panse et al., 2003).

Representative images of these

domains and their subcellular localizations are shown in Figure 5A and B.

As

previously reported, we found that the Ulp1 protein lacking region 2, (A2),
localized to the septin ring in the majority of large-budded, arrested cells
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(Makhnevych et al., 2007).

Therefore, region 2 of Ulp1 normally antagonizes

localization and/or retention at the septin ring. This result is complemented by
our novel finding that the full-length Ulp1(C580S) localized to the septin ring in 31%
of all arrested, large-budded cells (n>100) (Fig 3A and 5A).
Next, we investigated other residues of Ulp1 that could affect the septin ring
localization of the Ulp1(C580S) mutant, possibly by interfering with its targeting to
sumoylated substrates.

Aspartate 451 (D451) in Ulp1 is required to form an

essential salt-bridge with arginine 64 of Smt3 (lhara et al., 2007; Mossessova
and Lima, 2000).

Therefore, we introduced a D451N mutation into Ulp1(C580S)

and found that it abolished the accumulation of the full-length Ulp1 double mutant
(D451N, C580S) at the septin ring (Fig. 5A).

This finding underscores the

importance of Smt3 in targeting full length Ulp1 to the septin ring shown in Figure
4.

Additionally, it may indicate that aspartate 451 is required for targeting of

sumoylated proteins while the C580S mutation is required for retention of Ulp1 at
the septin ring.
Most intriguingly, we found that a truncation consisting only of region 3 with
the C580S mutation (Ulp1(3)(C580S)), displayed septin ring localization in 59% of
cells (Fig 3C (right panel) and Fig 5B).

In stark contrast, regions 1, 2, and

wildtype region 3, lacking the C580S mutation, failed to localize to the septin ring
(Fig. 5A and B). However, where Ulp1 is displaced, the septin ring stays intact
(data not shown).

Therefore, necessary and sufficient SUMO-dependent

targeting information is contained in region 3 of Ulp1 but not region 1 and 2. The
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Figure 5. Distinct and separate Ulp1 domains are required for localization
to the septin ring. (A and B) Left: Schematic representation of Ulp1 deletion and
truncation mutants used in this study. The length of each construct (amino acid
scale: 1-621), individual domains of Ulp1, and pertinent amino acid changes are
shown. WT: full-length Ulp1, region 1: Ulp1 (1-150) , region 2: Ulp1 (151 -340),
region 3: Ulp1 (341 -621), A2: Ulp1 lacking region 2, C580S: catalytically
inactivating mutation, D451N: deleted salt-bridge with SUMO. Colored letters N,
S, D summarize the observed nuclear, septin or diffuse localization of the
indicated constructs, respectively. SBS corresponds to a shallow SUMO-binding
surface on Ulp1 (28,51,52). Right: Representative images of G2/M arrested cells
expressing the GFP-tagged Ulp1 constructs shown on the left. The fraction of
cells (%) with nuclear, septin or diffuse localization and the presence and position
of bud-neck localized Ulp1 constructs is indicated (arrow heads). (C)
Quantification of distinct subcellular localization of wildtype and mutant Ulp1
region 3 constructs. Large-budded G2/M arrested cells were imaged to assess
either diffuse, nuclear, or bud-neck localization (n>100).

latter conclusion is also confirmed by two-hybrid assays with Smt3 (Fig. 9).
The previously published co-crystal structure of Ulp1 with Smt3 (MMDB
database # 13315) reveals that amino acids 418-447 of region 3 make extensive
contact with Smt3 and constitute an exposed SUMO-binding surface (SBS - see
also Fig. 6) (Mossessova and Lima, 2000). The SBS is situated next to, but does
not include, the critical D451 residue that contacts Smt3 (lhara et al., 2007).
Additionally,

deletion

of

this

SBS

in

region

3

of

Ulp1

abolishes

the

complementation of a u lp lA deletion mutant (Li and Hochstrasser, 2003). In an
attempt to identify critical residues in the evolutionary conserved SBS domain, we
used psi-blast to compare the protein sequence of the yeast Ulp1 catalytic
domain to all non-redundant protein sequences in the NCBI database for seven
iterations and limited the output to the top 250 matches.

While there was an

obvious bias toward model organisms for which more sequences were available,
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our results contained 81 different species; 61% of the sequences were identified
as verified or predicted sentrin/SUMO protease/Ulpl genes, 24% were identified
as unnamed protein products or hypothetical genes and 15% were “other”
(crystal

structures,

unanalyzed

sequence,

etc.).

The

alignment of these

sequences allowed us to identify areas of strong conservation (see figure 7A and
7B). Using this approach we identified several highly conserved residues in the
SBS.

However, these amino-acids did not contact Smt3 in the published co

crystal structure and likely play structural roles in Ulp1 folding (Mossessova and
Lima, 2000).

Smt3

U!p1 (3)

Figure 6. 3D co-crystal structure of Ulp1 Reg 3 and Smt3. Three dimensional
representation of the co-crystal structure of the catalytic domain of Ulp1 (Ulp1(3)
-- magenta) with yeast SUMO (Smt3 -- blue). Indicated in yellow and labeled
with the appropriate amino acids are N450, D451, and C580. Also shown is the
SUMO-binding surface (SBS).
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We also investigated the effect of deleting the entire SBS domain on the
localization of Ulp1(3){C580S). A Ulp1 (3)(C580S)ASBS construct does not localize to
the septin ring in the majority of cells (96%). The results match those obtained
by Li and Hochstrasser using a wildtype Ulp1(3)ASBS construct (C173) (Li and
Hochstrasser, 2003).

We also cloned and expressed the SBS domain as a

fusion with the green fluorescent protein (SBS-GFP). This construct distributed
diffusely throughout the cell and failed to localize to the septin ring (Fig. 5
middle). These data suggest that the SBS domain of region 3 may be required
for the initial interaction with sumoylated substrates but additional features of
Ulp1 are required for targeting (D451) and retention (C580S) of this SUMO
protease at the septins.
Next, we directed our attention to the temperature-sensitive ulp1ts-333
allele.

This mutant allele causes cells to arrest in mitosis and accumulate

unprocessed SUMO precursor and sumoylated proteins (Li and Hochstrasser,
1999).

Our u lp lts construct of region 3, Ulp1(3)ts, contains three mutations

(I435V, N450S, I504T), and introduction of C580S into Ulp1(3)ts showed a greatly
reduced incident and intensity of septin ring localization (compare panels in Fig.
5B and 5C). We noted that the (N450S) mutation in the ts construct was located
next to the salt-bridge forming residue D451 described above and that both
residues are highly conserved in the consensus sequence of Ulp1 -like molecules
(Fig. 7A and 7B). This suggested that residues altered in ulp1ts-333, specifically
N450, may contribute to Smt3 interaction and possibly substrate targeting.
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Figure 7. Identification of important features required for Ulp1 targeting
and SUMO-binding. (A) The yeast Ulp1 catalytic domain was blasted against all
non-redundant protein sequences in the NCBI database using psi-blast. After 7
iterations, the top 100 query sequences (only 11 are shown) were aligned, which
included a variety of animal, plant and fungal species. Shown in red are residues
that constitute the SUMO-binding surface (SBS). Also indicated are the saltbridge forming D451 and one of the residues mutated in the u lp lts allele, N450.
Conservation: conservation of amino acid properties. Quality', alignment quality
based on Blosum 62 scores; high values suggest no or conservative mutations.
Consensus: percent identity. Calculated using Jalview. (B): Consensus SBS
based on the alignment of 250 sequences from 81 species. The height of the
letters corresponds to the frequency of the amino acid in the alignment; width is
based on the proportion of sequences that contain a character (many gaps lead
to narrow letters). Also indicated are the salt-bridge forming D451 and one of the
residues mutated in the u lp lts allele, N450 (weblogo.threeplusone.com)(Crooks
et al., 2004).
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possible that N450S perturbs the salt-bridge interaction formed between D451 of
Ulp1 and R64 of Smt3 therefore reducing the interaction with Smt3 and
contributing to the temperature sensitive phenotype. In support of this, correction
of the N450S mutation in Ulp1(3)ts (S450N) partially rescued the slow growth defect
of a u lp lA strain at 30° and 37°C (data not shown).

The effect of the u lp lts

mutation on Ulp1 ’s ability to interact with Smt3 is explored in more detail below
(Fig. 9).
In conclusion we find that several features, most importantly D451 and
C580S, in region 3 of Ulp1, beyond the previously identified SBS domain, are
required for targeting and retention at the septin ring (see Fig. 5, 6 and 7).

Kap121-independent SUMO-targeting information resides in Ulp1(3)(C580S).
Above, we describe our identification of necessary and sufficient substratetargeting information in the catalytic domain (region 3) of Ulp1. However, region
3 of Ulp1 may not be the only domain involved in targeting to the septins. Region
1 of Ulp1, the Kap121-binding domain, has previously been implicated in septintargeting. Specifically, it has been reported that Kap121 is required for targeting
Ulp1 to the septin ring during mitosis (Makhnevych et al., 2007). Therefore, we
decided to assess the role of Kap121 in the substrate-targeting of Ulp1 (3){C580S).
Specifically, we used a kap121ts mutant (Leslie et al., 2002) to assess the septin
ring targeting of wildtype Ulp1, full-length Ulp1(C580S), and Ulp1(3)(C580S). In our
analysis, we found that full-length Ulp1(C580S) required Kap121 function for
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targeting to the septin ring.

At the permissive temperature (30°C), Ulp1(C580S)

demarcated the nuclear envelope and septin ring of G2/M arrested cells. After a
shift to the non-permissive temperature, however, Ulp1(C580S) could no longer be
detected at the septin ring (Fig. 8 - middle panel).

Surprisingly, Ulp1(3)(C580S),

was localized to the bud-neck at the permissive and non-permissive temperature
for kap121ts. As shown here at 30°C and 37°C, Ulp1 (3)<C580S>resided both inside
the nucleus and at the septin ring (Fig. 8 - right panel).

GFP:

Ulp1 (WT)

Ulp1<C580S>

Ulp1 (3)(C580S>

3 0 °C

3 7 °C
Figure 8. Kap121-independent SUMO-targeting information resides in
region 3 of Ulp1 (A) kap121ts cells were transformed with plasmids expressing
GFP-tagged wildtype (WT) Ulp1, uip1(C580S), and Ulp1(3)(C580S) under the control
of the Ulp1 promotor. Shown are representative images indicating the localization
of GFP-tagged Ulp1 constructs in large-budded cells at 30°C and 37°C, the nonpermissive temperature for kap121-ts. The position of bud-neck localized Ulp1
constructs is indicated (arrowheads).

Our

data

suggest that

Ulp1

contains

both

Kap121-dependent

and

independent bud-neck targeting information. The only requirement to detect full-
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length Ulp1 and Ulp1(3) at the bud-neck is the C580S mutation and functional
Kap121 (Fig. 3, 4, 5, and 8). In contrast Ulp1(3)(C580S), which lacks all domains
required for NPC interaction through Kap121, Kap60, and Kap95, localizes to the
budneck and inside the nucleus.

In summary, this finding provides strong

evidence that Kap121-independent bud-neck-targeting information resides in the
catalytic domain (region 3) of Ulp1.

Multiple features in the catalytic domain of Ulp1 affect SUMO interactions.
Our finding that a single amino-acid change in the catalytic domain of Ulp1
results in greatly enhanced, SUMO-dependent localization to the bud-neck also
prompted us to investigate the two-hybrid interactions of Ulp1(3)(C580S) with
budding yeast SUMO (Smt3-BD).

Full-length wildtype Ulp1, the full-length

catalytically inactive Ulp1(C580S) mutant, the Ulp1 Kap121-interacting domain
(region 1), the Ulp1 Kap60/Kap95-interacting domain (region 2), and the catalytic
domain (region 3) all failed to interact with Smt3 fused to the Gal4 DNA-binding
domain (data not shown).

However, the catalytically inactive Ulp1 (3)(C580S)

truncation interacted weakly, but reproducibly and above background, with Smt3
(see Fig. 9)
Next, we focused on the important residues near the SBS domain of Ulp1
region 3 (see Fig. 5B and 6). First, we investigated the D451N mutant of Ulp1
that prevents the interaction of Ulp1 with SUMO (lhara et al., 2007; Mossessova
and Lima, 2000)
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-T-L

-A

Figure 9. Distinct and separate Ulpl domains are required for interaction
with SUMO. (A) Two-hybrid analysis of various Ulp1 region 3 truncations with
SUMO (C580S: catalytically inactive; D451N: deleted salt-bridge with SUMO; ts:
mutations including S450N in ulp1ts-333). The presence of both Smt3
(pOBD2/TRP1) and Ulp1 constructs (pOAD/LEU2) was confirmed by growth on
medium lacking tryptophan and leucine (-T-L). The interaction between Ulp1
constructs and Smt3 is shown as duplicate streaks on media lacking adenine (A). See Fig. 5A and B for a graphic representation of individual constructs

As shown above, D451N, when introduced into Ulp1(C580S), prevented
localization to the septin ring (Fig 5A). Accordingly, we found that introduction of
the D451N mutation into Ulp1(3)(C580S) destroyed its interaction with Smt3 (see
Fig. 9). We reasoned that Ulp1(3)(C580S) alone fails to score strongly with Smt3
because it is avidly interacting with free Smt3 or is sequestered by sumoylated
proteins in the cell and, therefore, failed to interact with the BD-Smt3 fusion. We
therefore proposed that weakening of the interaction between Ulp1 (3)(C580S) and
Smt3 could allow for a two-hybrid interaction to be scored.

In support of this

hypothesis, we found that introducing the u lp lts mutations in the Ulp1 (3)(C580S)
construct, forming Ulp1(3)ts (C580S), also enhanced interaction with Smt3. These
observations provide evidence that the targeting of Ulp1

to sumoylated

substrates is a closely balanced act involving both Smt3 targeting and retention.
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The Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified proteins.
We hypothesized that if Ulp1(3)(C580S) were to interact avidly with Smt3, this
mutated moiety of Ulp1 could efficiently interact with SUMO adducts in vitro.
Therefore, to test the direct interaction of Ulp1(3)(C580S) with SUMO, we fused this
domain to the carboxy-terminus of the maltose binding protein (MBP) and
expressed

large amounts of the recombinant fusion

protein

in bacteria.

Subsequently, the MBP-Ulp1(3)(C580S) fusion protein was purified from bacterial
extracts and bound to amylose resin.

As a control to assess the ability of the

MBP-Ulp1(3)(C580S) to interact with sumoylated proteins, we also purified a
second

MBP-fused

Ulp1 (3)(C580S)

construct

lacking

the

SBS

domain

(3(C580S)ASBS).
First, we determined the ability of MBP-Ulp1 (3)(C580S) to affinity-purify
sumoylated proteins from crude yeast cell extracts. ulp1ts-333 cells expressing
FLAG-tagged-SMT3 (YOK428) were grown to log-phase prior to preparation of
yeast cell extracts (see material and methods).

These extracts were then

incubated with resin-bound MBP-Ulp1(3)(C580S), MBP-Ulp1(3)(C580S)-ASBS, or
unbound amylose resin.

After washing, bound yeast proteins were eluted,

separated on SDS-PAGE gels, and analyzed by western blotting with an antiFLAG antibody. Flag-SMT3-modified proteins present in the whole cell extracts
(WCE) (Fig. 10A lane 2) could clearly be detected bound to MBP-Ulp1(3)(C580S)
(lane 5) but not the MBP-Ulp1(3)(C580S)-ASBS control protein (lane 4).

We

identified both unconjugated Flag-Smt3 protein as well as several higher
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molecular weight adducts. These data suggest that Ulp1 (3)<C580S) can efficiently
bind and enrich sumoylated proteins from crude yeast cell extracts.

To

demonstrate the versatility of Ulp1(3)(C580S) -aided Smt3 purification, we also
purified monomeric and conjugated GFP-Smt3 from yeast cells (Fig. 10B).
Additionally, we probed extracts and eluted proteins shown in figure 10B with an
anti Cdc11

antibody,

revealing the specific co-purification of Cdc11

with

immobilized Ulp1 (3)(C580S) (Fig. 10C).
In the reciprocal experiment, we tested whether a GFP-tagged Ulp1(3)(C580S)
construct expressed in yeast cells could bind immobilized SUM 02 which is highly
conserved to yeast Smt3.

In this experiment, yeast cells expressing CEN-

plasmid levels of the GFP-tagged Ulp1 (3), Ulp1(3)(C580S), or the Ulp1(3)(C580S)ASBS (see Fig. 5) were grown to log-phase prior to preparation of yeast cell
extracts.

Individual extracts were then incubated with SU M 02 immobilized on

agarose beads (see material and methods). After washing, bound yeast proteins
were eluted, separated on SDS-PAGE gels, and analyzed by western blotting
with an anti GFP antibody.

This time, the GFP-tagged Ulp1 (3)(C580S) could be

detected in the WCE and bound to the SU M 02 agarose (Fig. 10D). In contrast,
neither the wildtype catalytic domain of Ulp1 (Ulp1(3)) nor Ulp1(3)(C580S)ASBS
bound to SUM02-agarose. Similarly, the Ulp1(3){C580S) could also be purified on
SUMO-1 agarose (data not shown).
We also analyzed if immobilized Ulp1(3)(C580S) could be used to purify
SUMO chains.

For this experiment, we incubated purified SUM 02 chains with
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our immobilized Ulp1(3)(C580S) or the unbound amylose resin.

After washing,

bound SU M 02 chains were eluted, separated on SDS-PAGE gels, and analyzed
by western blotting with an anti- SU M 02 antibody. SUM 02 chains could clearly
be detected in the input (Fig. 10E-lane 2) and bound to the MBP-Ulp1(3)(C580S)
(lane 4), but not the resin-only control (Fig. 10E-lane 3). Both lower and higher
molecular weight adducts of SU M 02 were purified with preference for higher
molecular weight chains (5-7mers).

These data suggest that the Ulp1(3)(C580S)

can efficiently bind and enrich SU M 02 chains in vitro and that the MBP fusion of
Ulp1 (3)(G580S) m ay a|So be useful for the purification of sumoylated proteins from
mammalian cells.
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Figure 10. The Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified
proteins. (A and B) Immobilized Ulp1(3)(C580S) was analyzed for its ability to
affinity-purify Smt3 from yeast whole cell extracts (WCE). WCEs containing
FLAG-tagged-Smt3 (left) or GFP-Smt3 (right) (input) were prepared under non
denaturing conditions and incubated with immobilized MBP-Ulp1(3)(C580S)
(3(C580S)), MBP-Ulp1 (3)(C580S) lacking the SUMO-binding surface (3(C580S)ASBS) or
unbound resin (amylose). After washing and elution, bound Smt3 and Smt3
conjugates were detected using either anti-Flag or anti-GFP antibodies. (C)
Immobilized Ulp1(3)(C580S) was analyzed for its ability to affinity-purify Cdc11 from
yeast WCEs. WCE containing GFP-Smt3 (YOK 1857) was prepared under non
denaturing conditions and incubated with immobilized MBP-Ulp1(3)(C580S), MBPUlp1 (3)(C580S) lacking the SUMO-binding surface (3(C580S)ASBS) or unbound resin
(amylose). After washing and elution, bound Cdc11 was detected using an antiCdc11 antibody.
Arrowhead indicates modified Cdc11. (D) WCEs from
logarithmically growing
yeast cells
expressing
GFP-tagged
Ulp1 (3),
Ulp1(3)(C580S), Ulp1(3)(C580S)ASBS (input) were prepared under non-denaturing
conditions. Extracts were then incubated with SUM 02 immobilized on agarose
beads. After washing and elution with sample buffer, bound proteins were
detected using an anti-GFP antibody. (E) SUM 02 chains were incubated with
resin-bound MBP-Ulp1(3)(C580S) or unbound resin (amylose). After washing and
elution with sample buffer, bound proteins were detected using an anti-SUM02
antibody. SUM 02 chains loading control (input).

Determination of Ulp1 3<C580S) binding affinity to immobilized SUMO-1
The ability of Ulp1 3(C580S) to bind SUMO and SUMO modified proteins led
us to further investigate the binding affinity between Ulp1 3(C580S) and SUMO-1.
Affinity constants of Ulp1 3<C580S) with SUMO-1 were determined using a Biacore
3000 surface plasmon resonance (SPR) instrument (Affina Biotechnologies,
Stamford CT) (Fig. 11 A).

The equilibrium dissociation constant between Ulp1

3(C58os) and suMO-1 was determined to be 1.29 x 10'8 M or 12.9 nM (Fig. 11B).
Previously, it has been demonstrated that the affinity of SIMs for SUMO is in the
range of 2-3 p.M (Hecker et al 2006). Thus, the interaction between Ulp1 3(C580S)
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and SUMO-1 is 150-230 times stronger than any previously described SIM and
SUMO interaction.
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Figure 11. Determination of affinity constants between Ulp1(3)(C580S) and
SUMO-1. (A) Surface plasmon resonance (SPR) technique was used to study
the binding kinetics between MBP-Ulp1(3)(C580S) and SUMO-1.
Biotinylated
SUMO-1 was immobilized on research grade streptavidin-coated sensor chips.
Purified MBP-Ulp1(3)(C580S) was injected as the soluble analyte at a flow rate of
20 ^il/min in running buffer (see materials and methods). The respective graph
indicates the interaction between Ulp1 3(C580S) and SUMO-1 at various
concentrations of MBP-Ulp1(3)(C580S). (B) Affinity constants between MBPUlp1 (3)(C580S) an(j biotinylated-SUMO-1 as determined using BIAevaluation
software.
Ka-association rate constant, Kd-dissociation rate constant, KD
equilibrium dissociation constant
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A SUM02-binding platform for substrate ubiquitylation.
Sumo-targeted ubiquitin ligase proteins (STUbLs) like the yeast Slx5/Slx8
heterodimer and the human

RNF4 protein efficiently ubiquitylate proteins

modified with SUMO chains (Geoffroy and Hay, 2009; Tatham et al., 2008).
These proteins interact with their respective sumoylated ubiquitylation targets
through SIMs.

STUbL reactions have been reconstituted in vitro, but the

purification of target proteins modified with SUMO chains has been both
technically difficult or prohibitively expensive.

The ability of Ulp1(3)(C580S) to

interact with SUMO may, therefore, provide a simple way to purify a SUMO-chain
modified STUbL target of choice.
To test if Ulp1 (3)(C580S) can serve as a platform to modify a purified protein
with SUMO-2 chains, we incubated the immobilized MBP-Ulp1(3)(C580S) with
SUMO-2 chains and removed unbound SUMO-2 chains by washing with buffer.
The MBP-Ulp1 (3)(C580S) SUMO-2 chain complex was then eluted and added into
a STUbL in vitro ubiquitylation reaction containing recombinant RNF4. Proteins
in the STUbL-mediated ubiquitylation assay were separated on SDS-PAGE gels,
and analyzed by western blotting with an anti-SUMO antibody. Consistent with
previous observations, we were able to detect ubiquitylated SUMO-2 chains after
the STUbL reaction (Fig. 12A). This ubiquitylation was dependent on RNF4 and
SU M 02 chains. Based on these results, we propose that the Ulp1(3)(C580S) may
provide a useful, widely applicable tool for the study of sumoylated proteins and
STUbL targets (Fig. 12B).
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Figure 12. MBP-Ulp1(3)(C580S) can serve as a SU M 02 binding platform for
STUbL-mediated substrate ubiquitylation. (A) SUMO-2 chains (Boston
Biochem) were incubated with resin-bound MBP-Ulp1(3)(C580S). The complex of
MBP-Ulp1(3)(C580S) with SUMO-2 chains was then eluted and added into an in
vitro ubiquitylation reaction with the STUbL E3 RNF4. Proteins in the STUbL
reactions were separated by SDS-PAGE and analyzed by western blotting with
an anti-SUM02 antibody. Arrows indicate modified SUMO-2 chains. L a n e l: no
SUMO chains; lane 2: no Rnf4; lane 3: no Ulp1(3)(C580S); lane 4: all reagents (B)
Proposed model for using MBP-Ulp1(3)(C580S) as a SUMO-2 binding platform for
substrate ubiquitylation. SUMO-2 (spheres labeled S), ubiquitin (spheres labeled
Ub). RNF4 (gray oval labeled RNF4).
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DISCUSSION:
In this study we demonstrated that region 3 of Ulp1, the catalytic domain,
contains

critical

information

for

the

subcellular

targeting

to

sumoylated

substrates, including the septin Cdc3. To determine how Ulp1 is targeted to its
substrates, we took advantage of a catalytically inactive Ulp1 mutant (C580S)
that exhibited a partial redistribution from the nuclear envelope to the bud-neck of
dividing yeast cells. The re-localization of Ulp1 depended on functional Smt3 and
sumoylated proteins at the bud-neck of dividing cells.
Importantly, using this novel Ulp1 in vivo septin-ring localization assay, we
traced the critical targeting information to two features in region 3 of Ulp1, a
previously identified SUMO-binding surface (SBS) (amino acids 418-447) and a
SUMO contacting residue (D451) that reside near the carboxy terminus of Smt3
(see Fig. 5). D451 of Ulp1 has previously been shown to contact Smt3 through a
salt bridge interaction (lhara et al., 2007; Mossessova and Lima, 2000).
Therefore, it is possible that perturbation of the D451 salt-bridge results in the
reduced ability to dock Smt3 in place once it has contacted the SBS domain.
Indeed, in our analysis, we provide evidence that the salt-bridge forming D451N
mutation abolishes the targeting of Ulp1 to septins and weakens the interaction of
the catalytic domain of Ulp1 with Smt3 (Fig 5A and 9).
The sole requirement for the enrichment of full-length Ulp1 at the septin ring
was the inactivating C580S mutation in the catalytic domain of Ulp1. This finding
has important implications for the Ulp1-targeting role played by the amino-
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Ulp1

Kao

Kao,
Uip1

Ulp1

Figure 13. Model. (A) Ulp1 is anchored to the nuclear pore complex (NPC) by
karyopherins (Kap) including Kap121 and Kap95-Kap60. During mitosis, Ulp1 is
released from the NPC and allowed access to the cytoplasm. Ulp1 is targeted to
cytoplasmic substrates (septins) via non-covalent interactions between its
catalytic domain and SUMO. (B) SUMO is required for proper septin ring
localization of Ulp1. Yeast mutant strains where sumoylation of the septins is
abolished no longer have proper Ulp1 localization at the bud-neck.

terminal karyopherin binding domains of Ulp1 (discussed below).

Additionally,

catalysis of Smt3 appears to be required for substrate release. The catalytically
inactive Ulp1(3)(C580S) mutant is prominently localized to the bud-neck and
nucleus of dividing yeast cells while the catalytically active wildtype Ulp1(3)
shows merely a diffuse staining throughout the cell (compare Fig. 5B top). This
is not due to different stabilities of either protein because both proteins are
expressed at equivalent levels (see Fig. 10D).

We propose, and show in our

biochemical analysis below, that the C580S mutation may trap a bound Smt3
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protein

in place,

allowing

us to observe

it in association

with

cellular

desumoylation substrates. In support of this assessment, combining the D451N
with the C580S mutation abolishes all visible bud-neck localization (Fig. 5A).
Therefore, we propose that Ulp1(C580S) first targets and docks Smt3 through the
SBS domain and the salt-bridge forming D451 residue prior to trapping it in place
due to its inability to cleave after the di-glycine motif of Smt3. We can assume
that a trapped substrate prevents further catalysis or interactions with other Smt3
molecules, an assessment that is borne out by our finding that despite its septintargeting and SUMO-binding properties, Ulp1 (3)(C580S) interacts only weakly with
Smt3 in a two-hybrid assay (Fig. 9).
sumoylated

substrate

is trapped

by

A better understanding of how the
Ulp1(3)(C580S)

may

have

important

implications for the rational design of inhibitors for Ulp1 -like SUMO proteases but
may have to wait for elucidation of the co-crystal structure with a trapped
substrate.
The interaction of budding yeast Ulp1 with Smt3 relies on multiple
hydrophobic and salt bridge interactions between the catalytic domain (region 3)
of Ulp1 and the carboxy-terminal extension of Smt3. Making multiple interactions
with Smt3, Ulp1 is particularly well suited to interact with a wide variety of
sumoylated substrates (Mossessova and Lima, 2000; Mukhopadhyay and
Dasso, 2007).

Other SUMO proteases, Ulp2 and several SENP proteins

(Senpl ,2,6,7), are believed to interact non-covalently with their sumoylated
substrates through dedicated SIMs (Kroetz et al., 2009; Mukhopadhyay and
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Dasso, 2007).

From our structure-function analysis of region 3, Ulp1 seems to

employ a unique mode of interaction with Smt3 and sumoylated substrates. Ulp1
does not appear to contain bona fide canonical SIMs and neither of the aminoterminal domains of Ulp1 (region 1 and 2) interact with Smt3 or become enriched
at the septin ring. This assessment is also underscored by the arrangement of
Smt3 and Ulp1 in the co-crystal structure (Mossessova and Lima, 2000).

The

hydrophobic groove of Smt3 that would interact with a SIM-containing protein is
turned away from the domains of Ulp1 that interact with Smt3. Interestingly, this
may suggest that Ulp1 can be recruited to proteins that are covalently or noncovalently modified with SUMO and SUMO chains.
Our research demonstrates for the first time that non-covalent interactions
between Ulp1 and SUMO are not only important for SUMO binding, but also for
the cytosolic targeting of this SUMO protease to the bud-neck and potentially
sumoylated septins (Fig. 13).

Septins are not the only cytosolic substrates of

Ulp1, but arguably the most prevalent (Johnson and Blobel, 1999; Takahashi et
al., 2000) and, therefore, may be readily scored in our bud-neck targeting assay
(Fig. 5A and 5B).

We predict that Ulp1 is also targeted to other cytosolic and

septin bound sumoylated substrate proteins, for example the karyogamy protein
Kar9 (Leisner et al., 2008).

However, due to the low local concentrations in

comparison to sumoylated septins, these proteins may be hard to detect.

We

propose, however, that sumoylated proteins that accumulate or aggregate in the
cytosol of yeast cells may be readily detectable by Ulp1(3)(C580S). As detailed
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below, Ulp1(3)(C580S) also provides a useful tool to purify these sumoylated
proteins (Fig. 10) and these studies are underway (Kerscher and Elmore,
unpublished results).

In conclusion, our findings provide strong evidence that

SUMO, at least in the case of sumoylated proteins at the septin ring, is a required
signal for the cytoplasmic targeting of Ulp1. Our alignments of the SBS domain
and the juxtaposed salt-bridge forming D451 residue reveals that this mode of
targeting may also be conserved in other metazoan Ulp1 -like SUMO-proteases
(Fig. 7 A and 7B).
Though we clearly show that Ulp1 becomes enriched at the bud-neck, we
do not yet fully understand how Ulp1 arrives at this subcellular localization. Our
findings support the previous observation that Kap121 plays an important role in
promoting Ulp1 targeting to the septin ring.

Similar to a previously described

Ulp1 mutant that lacks the Kap60/Kap95 binding domain (region 2) (Makhnevych
et al., 2007), the septin ring localization of the full-length Ulp1(C580S) protein
described here is dependent on functional Kap121.

It is unlikely that the

association with Kap121 shuttles Ulp1 to the septins.

Rather, as previously

reported, in mitosis Kap121 becomes associated with a transport inhibitory
nucleoporin, Nup53, and may thus exclude Ulp1 access to the inner phase of the
nuclear pore complex (Makhnevych et al., 2003).

This suggests that in the

absence of Kap121-binding, a fraction of Ulp1

is free to associate with

sumoylated septins.

Our studies confirm that Ulp1 lacking the Kap60/Kap95

binding domain (region 2) are enriched at the NPC and the septin ring (Fig. 5A).
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We extend these observations by showing that the ability to target sumoylated
septins resides in the catalytic domain (region 3) of Ulp1 (Fig. 5B). We find that a
Ulp1 (3)(C580S) mutant, but not wildtype Ulp1(3), is enriched at the septin ring in the
absence of Kap121.
Taken together, these data suggest that both the Ulp1 (3)(C580S) mutant and
WT Ulp1 (3) can interact with sumoylated septins but, unlike the subtrate-trapping
Ulp1(3)(C580S) mutant, the catalytically active WT Ulp1(3) may be quickly released
after desumoylation of the target protein giving it a diffuse appearance in the cell.
How Kap121 helps Ulp1-A2 to be retained at the septin ring in the absence of the
C580S mutation is currently not clear.

Kap121 may theoretically promote the

interaction with a bud-neck-localized protein.

However, the localization of

Kap121 to septins has not previously been reported.
One intriguing aspect of our study is the analysis of the substrate-trapping
Ulp1(3)(C580S) construct.

Detailed

binding

studies on the

avidity of the

Ulp1 (3)(C580S) protein with Smt3 are currently underway but three lines of evidence
reveal the avid interaction of Ulp1(3)(C580S) with SUMO proteins and sumoylated
substrates.

First, this Ulp1-derived construct shows a pronounced interaction

with the bud-neck comprised of sumoylated septins in vivo. Second, the reduced
interaction of Ulp1(3)(C580S) with Smt3 in a two-hybrid assay can be re-established
by introduction of mutations that weaken the interaction with Smt3. And third, the
purified,

recombinant Ulp1(3)(C580S) protein is a potent affinity-tag for the

purification of Smt3 conjugates and SUMO-modified proteins.
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A related study

involving the C603S mutant of the human SENP1
assessment of the substrate-trapping feature.

protease confirms our

The authors observe re

localization of their SENP1(C603S) mutant in vivo to promyelocytic leukemia
(PML) nuclear bodies and domains of the HDAC4 protein, suggesting that
SUMO-dependent-targeting may be a conserved feature of Ulp1 -like SUMO
proteases (Bailey and O'hare, 2004).

The latter may also provide a useful

strategy for the identification of mitotically important desumoylation substrates.
Indeed, two-hybrid screens with Ulp1(3)(C580S) in the lab have already identified
several

novel

cytosolic

unpublished observations).

desumoylation

targets

(Donaher

and

Kerscher

Finally, we are also exploring the ability of

Ulp1 (3)(C580S) to act as a SUMO-chain binding-tag that can be used to promote
the interaction of putative STUbL target proteins with RNF4 and other STUbLs
(Fig. 12).
Flow Ulp1 and other SUMO proteases target specific mitotic substrates for
desumoylation remains unknown.

Our analysis of SUMO-dependent Ulp1-

targeting to the septin ring provides important evidence that Ulp1 -like SUMO
proteases do not passively await their desumoylation substrates but rather
dynamically localize to them in a cell cycle specific manner. Future experiments
that take advantage of the SUMO-binding properties of the substrate-trapping
Ulp1 (3)(C580S) construct may prove useful for the identification of clinically relevant
targets of conserved Ulp1 -like SUMO proteases in yeast and human cells.

51

ACKNOWLEDGEMENTS

I dedicate this thesis to my family, especially my mother who always encouraged
me in my studies and helped me develop a love of learning that continues to this
day.

We would like to thank all members of the Kerscher lab for their support and hard
work and especially Cecilia Esteban for Figure 3B.

We are indebted to Diane

Shakes and Rachael Felberbaum for comments and edits of the manuscript.
Additionally, we would like to thank Vikram Panse, Maria Katariina Veisu, Sue
Biggins, Mark Hochstrasser, Eric Rubenstein, Munira Basrai, Wei Chun Au, Rick
Wozniak, Erica Johnson, Liz Allison, Mark Forsyth, and Eric Engstrom for strains
and reagents.

We would also like to thank Alexander Vinitsky at Affina

Biotechnologies for his help with the Biacore 3000 measurements used in this
study. This work was supported by NIH grant R15-GM085792 to O.K., a William
& Mary Howard Hughes Undergraduate Summer Research Fellowship to MD and
BCM, an Arts and Sciences Graduate Research Grant to ZCE and an ALSAM
fellowship to BCM.

52

References:

Baba, D., N. Maita, J.G. Jee, Y. Uchimura, H. Saitoh, K. Sugasawa, F. Hanaoka,
H. Tochio, H. Hiroaki, and M. Shirakawa. 2005. Crystal structure of
thymine DNA glycosylase conjugated to SUMO-1. Nature. 435:979-982.
Bailey, D., and P. O'hare. 2004. Characterization of the localization and
proteolytic activity of the SUMO-specific protease, SENP1. Journal of
Biological Chemistry. 279:692-703.
Baldwin, M.L., J.A. Julius, X.Y. Tang, Y.C. Wang, and J. Bachant. 2009. The
yeast SUMO isopeptidase Smt4/Ulp2 and the polo kinase Cdc5 act in an
opposing fashion to regulate sumoylation in mitosis and cohesion at
centromeres. Cell Cycle. 8:3406-3419.
Betting, J., and W. Seufert. 1996. A yeast Ubc9 mutant protein with temperaturesensitive in vivo function is subject to conditional proteolysis by a ubiquitinand proteasome-dependent pathway. Journal of Biological Chemistry.
271:25790-25796.
Biggins, S., N. Bhalla, A. Chang, D.L. Smith, and A.W. Murray. 2001. Genes
involved in sister chromatid separation and segregation in the budding
yeast Saccharomyces cerevisiae. Genetics. 159:453-470.
Bylebyl, G.R., I. Belichenko, and E.S. Johnson. 2003. The SUMO isopeptidase
Ulp2 prevents accumulation of SUMO chains in yeast. Journal of
Biological Chemistry. 278:44113-44120.
Chen, Z.J.J., and L.J.J. Sun. 2009. Nonproteolytic Functions of Ubiquitin in Cell
Signaling. Molecular Cell. 33:275-286.
Crooks, G.E., G. Hon, J.M. Chandonia, and S.E. Brenner. 2004. WebLogo: A
sequence logo generator. Genome Research. 14:1188-1190.
Dasso, M. 2008. Emerging roles of the SUMO pathway in mitosis. Cell Division.
3:-.
Flint, A.J., T. Tiganis, D. Barford, and N.K. Tonks. 1997. Development of
"substrate-trapping" mutants to identify physiological substrates of protein
tyrosine phosphatases. Proceedings o f the National Academy of Sciences
of the United States o f America. 94:1680-1685.

53

Geoffroy, M.C., and R.T. Hay. 2009. An additional role for SUMO in ubiquitinmediated proteolysis. Nature Reviews Molecular Cell Biology. 10:564-568.
Guthrie, C., and G.R. Fink. 1991. Guide to yeast genetics and molecular biology.
Academic Press, San Diego, xxxvii, 933 p. pp.
Hannich, J.T., A. Lewis, M.B. Kroetz, S.J. Li, H. Heide, A. Emili, and M.
Hochstrasser. 2005. Defining the SUMO-modified proteome by multiple
approaches in Saccharomyces cerevisiae. Journal o f Biological Chemistry.
280:4102-4110.
Hecker, C.M., M. Rabiller, K. Haglund, P. Bayer, and I. Dikic. 2006. Specification
of SUM 01- and SUM02-interacting motifs. Journal of Biological
Chemistry. 281:16117-16127.
Ihara, M., H. Koyama, Y. Uchimura, H. Saitoh, and A. Kikuchi. 2007. Noncovalent
binding of small ubiquitin-related modifier (SUMO) protease to SUMO is
necessary for enzymatic activities and cell growth. Journal of Biological
Chemistry. 282:16465-16475.
Johnson, E.S., and G. Blobel. 1999. Cell cycle-regulated attachment of the
ubiquitin-related protein SUMO to the yeast septins. Journal o f Cell
Biology. 147:981-993.
Johnson, E.S., and A.A. Gupta. 2001. An E3-like factor that promotes SUMO
conjugation to the yeast septins. Cell. 106:735-744.
Kerscher, O. 2007. SUMO junction - what's your function? New insights through
SUMO-interacting motifs. Embo Reports. 8:550-555.
Kerscher, O., R. Felberbaum, and M. Hochstrasser. 2006. Modification of
proteins by ubiquitin and ubiquitin-like proteins. Annual Review o f Cell and
Developmental Biology. 22:159-180.
Kroetz, M.B., D. Su, and M. Hochstrasser. 2009. Essential Role of Nuclear
Localization for Yeast Ulp2 SUMO Protease Function. Molecular Biology
o f the Cell. 20:2196-2206.
Lamsoul, I., J. Lodewick, S. Lebrun, R. Brasseur, A. Burny, R.B. Gaynor, and F.
Bex. 2005. Exclusive ubiquitination and sumoylation on overlapping lysine
residues mediate NF-kappa B activation by the human T-cell leukemia
virus tax oncoprotein. Molecular and Cellular Biology. 25:10391-10406.

54

Leisner, C., D. Kammerer, A. Denoth, M. Britschi, Y. Barral, and D. Liakopoulos.
2008. Regulation of mitotic spindle asymmetry by SUMO and the spindleassembly checkpoint in yeast. Current Biology. 18:1249-1255.
Leslie, D.M., B. Grill, M.P. Rout, R.W. Wozniak, and J.D. Aitchison. 2002.
Kap121p-mediated nuclear import is required for mating and cellular
differentiation in yeast. Molecular and Cellular Biology. 22:2544-2555.
Lewis, A., R. Felberbaum, and M. Hochstrasser. 2007. A nuclear envelope
protein linking nuclear pore basket assembly, SUMO protease regulation,
and mRNA surveillance. Journal of Cell Biology. 178:813-827.
Li, S.J., and M. Hochstrasser. 1999. A new protease required for cell-cycle
progression in yeast. Nature. 398:246-251.
Li, S.J., and M. Hochstrasser. 2003. The Ulp1 SUMO isopeptidase: distinct
domains required for viability, nuclear envelope localization, and substrate
specificity. Journal of Cell Biology. 160:1069-1081.
Makhnevych, T., C.P. Lusk, A.M. Anderson, J.D. Aitchison, and R.W. Wozniak.
2003. Cell cycle regulated transport controlled by alterations in the nuclear
pore complex. Cell. 115:813-823.
Makhnevych, T., C. Ptak, C.P. Lusk, J.D. Aitchison, and R.W. Wozniak. 2007.
The role of karyopherins in the regulated sumoylation of septins. Journal
o f Cell Biology. 177:39-49.
Makhnevych, T., Y. Sydorskyy, X.F. Xin, T. Srikumar, F.J. Vizeacoumar, S.M.
Jerarn, Z.J. Li, S. Bahr, B.J. Andrews, C. Boone, and B. Raught. 2009.
Global Map of SUMO Function Revealed by Protein-Protein Interaction
and Genetic Networks. Molecular Cell. 33:124-135.
Matic, I., M. van Hagen, J. Schimmel, B. Macek, S.C. Ogg, M.H. Tatham, R.T.
Hay, A.I. Lamond, M. Mann, and A.C.O. Vertegaal. 2008. In vivo
identification of human small ubiquitin-like modifier polymerization sites by
high accuracy mass spectrometry and an in vitro to in vivo strategy.
Molecular & Cellular Proteomics. 7:132-144.
Matunis, M.J., X.D. Zhang, and N.A. Ellis. 2006. SUMO: the glue that binds.
Developmental Cell. 11:596-597.
Mossessova, E., and C.D. Lima. 2000. Ulp1-SUMO crystal structure and genetic
analysis reveal conserved interactions and a regulatory element essential
for cell growth in yeast. Molecular Cell. 5:865-876.

55

Mukhopadhyay, D., F. Ayaydin, N. Kolli, S.H. Tan, T. Anan, A. Kametaka, Y.
Azuma, K.D. Wilkinson, and M. Dasso. 2006. SUSP1 antagonizes
formation of highly SUM02/3-conjugated species. Journal of Cell Biology.
174:939-949.
Mukhopadhyay, D., and M. Dasso. 2007. Modification in reverse: the SUMO
proteases. Trends in Biochemical Sciences. 32:286-295.
Mukhopadhyay, D., and M. Dasso. 2010. The fate of metaphase kinetochores is
weighed in the balance of SUMOylation during S phase. Cell Cycle.
9:3194-3201.
Nishihama, R., J.H. Schreiter, M. Onishi, E.A. Vallen, J. Hanna, K. Moravcevic,
M.F. Lippincott, H. Han, M.A. Lemmon, J.R. Pringle, and E. Bi. 2009. Role
of Inn1 and its interactions with Hof1 and Cyk3 in promoting cleavage
furrow and septum formation in S. cerevisiae. The Journal of cell biology.
185:995-1012.
Palancade, B., X.P. Liu, M. Garcia-Rubio, A. Aguilera, X.L. Zhao, and V. Doye.
2007. Nucleoporins prevent DNA damage accumulation by modulating
Ulp1 -dependent sumoylation processes. Molecular Biology o f the Cell.
18:2912-2923.
Panse, V.G., B. Kuster, T. Gerstberger, and E. Hurt. 2003. Unconventional
tethering of Ulp1 to the transport channel of the nuclear pore complex by
karyopherins. Nature Cell Biology. 5:21-27.
Perry, J.J.P., J.A. Tainer, and M.N. Boddy. 2008. A SIM-ultaneous role for SUMO
and ubiquitin. Trends in Biochemical Sciences. 33:201-208.
Sarge, K.D., and O.K. Park-Sarge. 2009. Sumoylation and human disease
pathogenesis. Trends Biochem Sci. 34:200-205.
Schwartz, D.C., R. Felberbaum, and M. Hochstrasser. 2007. The ulp2 SUMO
protease is required for cell division following termination of the DNA
damage checkpoint. Molecular and Cellular Biology. 27:6948-6961.
Sesaki, H., and R.E. Jensen. 1999. Division versus fusion: D nm lp and Fzolp
antagonistically regulate mitochondrial shape. Journal of Cell Biology.
147:699-706.
Song, J., Z.M. Zhang, W.D. Hu, and Y. Chen. 2005. Small ubiquitin-like modifier
(SUMO) recognition of a SUMO binding motif - A reversal of the bound
orientation. Journal of Biological Chemistry. 280:40122-40129.

56

Spiliotis, E.T. 2010. Regulation of Microtubule Organization and Functions by
Septin GTPases. Cytoskeleton. 67:339-345.
Stade, K., F. Vogel, I. Schwienhorst, B. Meusser, C. Volkwein, B. Nentwig, R.J.
Dohmen, and T. Sommer. 2002. A lack of SUMO conjugation affects
cNLS-dependent nuclear protein import in yeast. Journal o f Biological
Chemistry. 277:49554-49561.
Stelter, P., and H.D. Ulrich. 2003. Control of spontaneous and damage-induced
mutagenesis by SUMO and ubiquitin conjugation. Nature. 425:188-191.
Strunnikov, A.V., L. Aravind, and E.V. Koonin. 2001. Saccharomyces cerevisiae
SMT4 encodes an evolutionarily conserved protease with a role in
chromosome condensation regulation. Genetics. 158:95-107.
Subramaniam, S., K.M. Sixt, R. Barrow, and S.FI. Snyder. 2009. Rhes, a Striatal
Specific Protein, Mediates Mutant-Fluntingtin Cytotoxicity. Science.
324:1327-1330.
Sydorskyy, Y., T. Srikumar, S.M. Jeram, S. Wheaton, F.J. Vizeacoumar, T.
Makhnevych, Y.T. Chong, A.C. Gingras, and B. Raught. 2010. A Novel
Mechanism for SUMO System Control: Regulated Ulp1 Nucleolar
Sequestration. Molecular and Cellular Biology. 30:4452-4462.
Takahashi, Y., M. Iwase, M. Konishi, M. Tanaka, A. Toh-e, and Y. Kikuchi. 1999.
Smt3, a SUMO-1 homolog, is conjugated to Cdc3, a component of septin
rings at the mother-bud neck in budding yeast. Biochemical and
Biophysical Research Communications. 259:582-587.
Takahashi, Y., M. Iwase, A.V. Strunnikov, and Y. Kikuchi. 2008. Cytoplasmic
sumoylation by PIAS-type Siz1-SUMO ligase. Cell Cycle. 7:1738-1744.
Takahashi, Y., J. Mizoi, A. Toh-e, and Y. Kikuchi. 2000. Yeast Ulp1, an Smt3specific protease, associates with nucleoporins. Journal o f Biochemistry.
128:723-725.
Takahashi, Y., A. Toh-e, and Y. Kikuchi. 2001. A novel factor required for the
SUM01/Sm3 conjugation of yeast septins. Gene. 275:223-231.
Tatham, M.H., M.C. Geoffroy, L. Shen, A. Plechanovova, N. Flattersley, E.G.
Jaffray, J.J. Palvimo, and R.T. Flay. 2008. RNF4 is a poly-SUMO-specific
E3 ubiquitin ligase required for arsenic-induced PML degradation. Nature
Cell Biology. 10:538-546.

57

Uzunova, K., K. Gottsche, M. Miteva, S.R. Weisshaar, C. Glanemann, M.
Schnellhardt, M. Niessen, H. Scheel, K. Hofmann, E.S. Johnson, G.J.K.
Praefcke, and R.J. Dohmen. 2007. Ubiquitin-dependent proteolytic control
of SUMO conjugates. Journal of Biological Chemistry. 282:34167-34175.
Wang, Y.G., and M. Dasso. 2009. SUMOylation and deSUMOylation at a glance.
Journal o f Cell Science. 122:4249-4252.
Wilkinson, K.A., and J.M. Henley. 2010. Mechanisms, regulation and
consequences of protein SUMOylation. Biochemical Journal. 428:133-145.
Winzeler, E.A., D.D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre,
R. Bangham, R. Benito, J.D. Boeke, H. Bussey, A.M. Chu, C. Connelly, K.
Davis, F. Dietrich, S.W. Dow, M. El Bakkoury, F. Foury, S.H. Friend, E.
Gentalen, G. Giaever, J.H. Hegemann, T. Jones, M. Laub, H. Liao, N.
Liebundguth, D.J. Lockhart, A. Lucau-Danila, M. Lussier, N. M'Rabet, P.
Menard, M. Mittmann, C. Pai, C. Rebischung, J.L. Revuelta, L. Riles, C.J.
Roberts, P. Ross-MacDonald, B. Scherens, M. Snyder, S. SookhaiMahadeo, R.K. Storms, S. Veronneau, M. Voet, G. Volckaert, T.R. Ward,
R. Wysocki, G.S. Yen, K. Yu, K. Zimmermann, P. Philippsen, M. Johnston,
and R.W. Davis. 1999. Functional characterization of the S. cerevisiae
genome by gene deletion and parallel analysis. Science. 285:901-906.
Wykoff, D.D., and E.K. O'shea. 2005. Identification of sumoylated proteins by
systematic immunoprecipitation of the budding yeast proteome. Molecular
& Cellular Proteomics. 4:73-83.
Zhang, H., H. Saitoh, and M.J. Matunis. 2002. Enzymes of the SUMO
modification pathway localize to filaments of the nuclear pore complex.
Molecular and Cellular Biology. 22:6498-6508.
Zhao, X.L., and G. Blobel. 2005. A SUMO ligase is part of a nuclear multiprotein
complex that affects DNA repair and chromosomal organization (vol 102,
pg 4777, 2005). Proceedings o f the National Academy of Sciences o f the
United States o f America. 102:9086-9086.
Zhao, X.L., C.Y. Wu, and G. Blobel. 2004. Mlp-dependent anchorage and
stabilization of a desumoylating enzyme is required to prevent clonal
lethality. Journal o f Cell Biology. 167:605-611.

58

